far too many American start-ups working on cutting-edge technologies with applications important to our defense mission are having a difficult time accessing investment to scale their research to production.
Gillibrand highlights the funding challenges faced by American defense technology start-ups.
Share
More from Kirsten Gillibrand
I ask my colleagues, how many more servicemembers will we lose, how many more billions of dollars must families pay at the pump, how many more empty promises must be made from an out of control administration before this body finally acts?
Americans’ access to lifesaving medication should not rely on supply chains controlled by foreign countries. The Pharmaceutical Investment Oversight and Accountability Act would help shine a light on foreign influence in our drug supply…
Other voices in this conversation
